Stem Cell Related Donor Safety Study (RDSafe)
The study tests the hypothesis that related hematopoietic stem cell donors are at a higher risk for acute medical and psychological toxicity associated with the donation process compared to adult unrelated hematopoietic stem cell donors.
The study will also assess the hypothesis that young (<18 years) and older (>60 years) related donors are at increased risk for toxicity associated with donation compared to younger adult donors by describing the adverse events reported in these populations.
An ancillary study of the psychological impact of donation on health-related quality of life (HRQoL) will enroll related donors and compare them to an age-matched normative cohort.
|Related Hematopoietic Stem Cell Donors|
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life|
|Study Start Date:||January 2010|
|Study Completion Date:||September 2016|
|Primary Completion Date:||August 2015 (Final data collection date for primary outcome measure)|
Related Hematopoietic Stem Cell Donors
Please refer to this study by its ClinicalTrials.gov identifier: NCT00948636
Show 52 Study Locations
|Principal Investigator:||Michael A Pulsipher, M.D.||Children's Hospital Los Angeles|